New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Tuesday, September 29

Tuesday, September 29, 2026

Everything we published on this day.

72 stories — the front page that day →

@kevin__mak

Kevin Mak on X

$QURE A bunch has been written about today's AMT130 news by people far more scientifically credible than me, so I'll just summarize to say my opinion is that the data was directionally bearish but only mildly. I think the reaction to the news was overblown. If you gave me the press release and conference call ahead of time and asked me to guess "what does the price trade to", I'd say around $32. Lots of people have complained about the type and quality of disclosure and messaging from the company but I want to highlight something I noticed that I think has been missed. My experience this morning was that the actual press release process was entirely mishandled. Here's what I think happened: 7:05AM ET is the "typical release time" for QURE. So naturally when they setup an interview with Stat News and Bloomberg the night before, they likely communicated this "embargo time". So at 7:05AM, the pre-written articles from Stat and Bloomberg hit the newswires. Bloomberg's article was particularly poorly done, with exceptionally little detail beyond the "-44% not stat sig" datapoint. (They later "updated" their news article to be more robust). But this awful article was essentially first to hit the headlines, and obviously thousands of bots and machines are scraping Bloomberg, and trading off it. Naturally one would want to "check for more data beyond two articles", but for some reason, at 7:05AM, there was no Press Release from QURE. This was likely a mistake (either by QURE or by the wire company). In the screenshot (and link) below, you'll see the timestamp of the official wire including ALL of the data. So investors were "left in the dark" for a full 7 minutes. Does 7 minutes really matter? To a long term investor, certainly not. But it matters to algo traders, who leave footprints of price action, which affect sentiment, so it does matter. Also, it leaves me unsettled that they're possibly getting some of the most basic things wrong. I get their jobs are stressful and there's a lot on the line here, that's why you have to dot your i's, cross your t's, because everything matters. To be clear, I don't know for a fact who's error this was, but I'd speculate it was the company. (Here's a normal press release from the company timestamped at 7:05AM ET. There are many other examples on the site that corroborate the 7:05 ET pattern) Disclosure: Creek Drive and its affiliated funds hold a long position in QURE. Views expressed are current opinions for information only, subject to change and are not investment advice or a recommendation to buy or sell any security. Investing involves the risk of loss and past performance is not indicative of future performance. See the disclosures link in my bio for more important information.

Toll roads in the sky

Asia's elevator boom favors maintenance and modernization providers, with Otis deriving nearly 90% of operating profit from after-sales…

OTIS $30B
Asian Century Stocks 2 clicks
@DeepSailCapital

Deep Sail Capital on X

Added back $CRCT short too: One time tariff impacts make the financials look good, but the company is in structural decline: $26.7M of the $47.4M operating income was non-recurring $20.3M of IEEPA tariff refunds and a $6.4M royalty reserve release. Strip them and operating income is roughly half what printed, on revenue that fell 9%. The rest of the bear case: Hardware is in structural decline — down 22%, with lower ASPs on the Joy 2 and Explore 5 launches and heavier promotion. A razor-and-blades model where the razors are shrinking. Platform growth is 5% and subscribers grew 3% to 3.10M. That's the "good" half, and it isn't growing fast enough to carry a declining hardware base. Engagement is flat, not recovering. 90-day engaged users 3.49M against 3.48M. Management framed stabilising active users as a win, which tells you the trend it's stabilising from. Tariff refunds do not repeat. The Q2 comp next year is brutal.
@convequity

Convequity on X

Batch size sets the trade-off between speed and cost in AI inference. An AI server answers many users at once by bundling their requests into one batch. Our $CBRS note compares this to running a bus. There are two ways to run it, and each gives something up. 1. Fill the bus. Put as many passengers as possible on every run. More stops slow each passenger's trip, but the cost of the run is spread across more people, so the cost per passenger falls. Larger batches do the same: each user's answer is slower, and the cost per token falls because the system produces more tokens from the same hardware. 2. Carry fewer passengers and stop less. Each trip is faster, but fewer seats mean the cost of the run is spread less well, so the cost per passenger rises. Smaller batches are fast for one user and raise the cost per token. So in the analogy, speed for each user is how fast each passenger arrives. Cost per token is cost per passenger. A system set up for one gives up some of the other. When someone compares two inference systems, check the batch size behind each number. A speed figure or a cost-per-token figure quoted without it cannot be compared fairly.
@KEDM_COM

KEDM.com on X

ProQR Therapeutics $PRQR CEO Daniel de Boer bought $513K across two separate purchases on July 7 and July 9, and a company director bought another $229.5K in late June (real money for a Dutch CEO). PRQR is a small-cap RNA-editing biotech backed by a major pharma partner: Eli Lilly. Their collaboration, running since 2021 and expanded in 2022, could pay ProQR up to $3.75 billion in milestones plus royalties, real validation for a company this size. The balance sheet just got stronger too: ProQR raised roughly $59 million in late June 2026, with Lilly buying in alongside the public offering to keep its stake intact, a vote of confidence from the partner who knows their science best.
@DOMOCAPITAL

DOMO Capital Management, LLC on X

Why a $MNRO sale is likely imminent: The quarter after the Chairman, Solomon,received millions of shares in exchange for giving up his right to veto a sale of the company - the company initiated a strategic review that was in "preliminary stages." Last quarter that changed to "well underway" and the "financial and legal advisors" became "independent financial advisors Bank of America and Solomon Partners." In regards to valuation. The CEO has a comp package that essentially doubles his outstanding shares if the stock hits $25 and triples them if the stock hits $30. An announcement of a sale of $MNRO appears to be imminent (before year end) especially since Icahn just closed on Pep Boys sale to Mavis and a sale price of $MNRO of at least $25 but possibly $30+ seems probable.